(Q43985638)

28 November 2017

Bendamustine mitoxantrone and rituximab (BMR): a new effective regimen for refractory or relapsed indolent lymphomas (English)

1 reference

28 November 2017

1 reference

1 reference

Rudolf Weide

1

1 reference

28 November 2017

Jochen Heymanns

series ordinal

2

1 reference

28 November 2017

Annette Gores

series ordinal

3

1 reference

28 November 2017

Hubert Köppler

series ordinal

4

1 reference

28 November 2017

1 February 2002

1 reference

28 November 2017

1 reference

28 November 2017

43

1 reference

28 November 2017

327-331

1 reference

28 November 2017

2

1 reference

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

28 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F10428190290006107

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F10428190290006107

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F10428190290006107

10.1080/10428190290006107

21 January 2018

Identifiers

DOI

1 reference

release_lej4dj23hfctdfkdtwh4yc4bvi

28 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lej4dj23hfctdfkdtwh4yc4bvi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference